CLINICAL_TRIALS
trial_result
· 2018-01-18
Clinical Trial Update: GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer [Phase 2]
Summary
Phase 2 trial evaluating cisplatin plus irinotecan for biliary cancer (gallbladder or biliary tract cancer). Status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hospital de Cancer de Barretos - Fundacao Pio XII | Conditions: Biliary Cancer | Phase 2 | Status: UNKNOWN